NCT05024981 Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident
| NCT ID | NCT05024981 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Cerebrovascular Accident |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2022-03-04 |
| Primary Completion | 2027-01-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2022-03-04 with a primary completion date of 2027-01-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cerebrovascular Accident affects the majority of the elderly population and its frequency is constantly increasing. The resulting deficits are numerous and lead in particular to an alteration in the quality of walking and autonomy. Numerous rehabilitation techniques have been described. In practice, correction instructions are often given by the therapist while the motor activity is being performed. Walking is a complex activity, as is the processing of dual-task information in elderly stroke patients. It therefore appears interesting to separate the time of motor realization and that of correction instructions. Investigators therefore propose firstly to film the patient during the performance of a walking activity and then, secondly, to analyse the video with the patient, which thus represents a source of delayed feedback. The main objective of the study is to observe the effects of this practice on walking speed. Investigators are comparing two groups of patients: the control group receiving conventional rehabilitation and the experimental group receiving conventional rehabilitation plus sessions with the video tool. They expect to observe a greater improvement in walking speed in the experimental group.
Eligibility Criteria
Inclusion Criteria: * Hospitalization for a first episode of Cerebrovascular Accident less than six months old, or nth stroke less than six months old, with no previous sequelae; * Able to walk at least 10m without stopping, with or without technical assistance, but without human assistance, under supervision; Exclusion Criteria: * Palliative or life-threatening situation; * A patient whose guardian or trustee is not readily available to provide information about the patient * Neuro-cognitive disorder that prevents understanding of instructions, as determined by the clinician; * Severe speech or language disorder that prevents the protocol from being carried out correctly; * Hemineglect; * Any previously known pathology altering the gait pattern, at the clinician's discretion (recent neurological, traumatological or orthopaedic pathologies, etc.); * Visual disorder preventing viewing of the video; * Hearing disorder preventing comprehension.
Contact & Investigator
Audrey MARTEU
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Frequently Asked Questions
Who can join the NCT05024981 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Cerebrovascular Accident. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05024981 currently recruiting?
Yes, NCT05024981 is actively recruiting participants. Contact the research team at marteu.a@chu-nice.fr for enrollment information.
Where is the NCT05024981 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT05024981 clinical trial?
NCT05024981 is sponsored by Centre Hospitalier Universitaire de Nice. The principal investigator is Audrey MARTEU at Centre Hospitalier Universitaire de Nice. The trial plans to enroll 64 participants.